B

Baroness Cash (Con)

Speaking in the House of Lords on 17 November 2026

Debate

Health Bill

Contribution

My Lords, I am grateful to all noble Lords who have spoken in this important group. I am particularly grateful to my noble friend Lady Davies and the noble Baroness, Lady Cass, for tabling their amendments. It is pleasing, to say the least, to see consensus emerging in this area, because we are talking about some of the most vulnerable young people likely to encounter healthcare. The amendments in this group share some objectives: the treatment of children and young adults for gender distress needs to rest on evidence, as the noble Baroness, Lady Barker, rightly pointed out; and we must be absolutely clear on who is accountable for the services provided to them. I support my noble friend’s Amendments 75, 275 and 276, which really amount to questions about accountability. I am grateful to the noble Lord, Lord Scriven, for saving me from making some of the same points and asking some of the same questions of the Minister. I largely agree with what he posed in respect of accountability around the standards of care to be applied. I am also grateful for the expertise of the noble Baroness, Lady Cass, and the noble Lord, Lord Singh, to whom I defer as practitioners with expertise in the care of children, and in mental health and therapeutic care in the case of the noble Lord. Evidence is being heard by the Select Committee at the moment in pre-legislative scrutiny, but it is an enormous worry that, listening to the medical expertise today, it is unclear to practitioners that they will be safe to carry out what everyone who has spoken today agrees on regarding the safety of care of these young people. It needs to be possible, as the noble Lord, Lord Scriven, said, to explore autism, anxiety or any of the other comorbidities we know about. We also know that a very high proportion of cared-for children present with gender dysphoria. I noted that, with her typical wisdom, the noble Baroness, Lady Cass, distinguished between sexual orientation and gender dysphoria because of the significance of desisting and detransitioning which takes place around gender dysphoria. It is far from clear in many of these young people. In fact, there is data to suggest that the majority of them desist and grow up to be young gay people. I am pleased that we have finally achieved some consensus in all this and understood that, together, our priority is the right care and standards for these young people. It is in that spirit that I have tabled Amendment 279QQ on the prescribing of masculinising and feminising hormones—I will say, “cross-sex hormones”, if noble Lords do not mind, because that is quite a mouthful, although I appreciate the correct terminology—for children under 18. The Government deserve credit for the steps they have already taken regarding puberty blockers, a ban they made permanent in 2025. They also stopped the starting of new prescriptions for cross-sex hormones, as the noble Lord, Lord Scriven, pointed out, under the then Health Secretary, Wes Streeting, who explained in full to Parliament why he had done that, with the evidence reviews finding very limited and weak evidence to support their use. GPs have been advised not to enter shared care with unregulated providers. All those steps taken by this Government were right, and I support them.

More from Baroness Cash (Con)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.